Cold chain

#Acquisition #Biopharma #Biotechnology #CDMO #Cell and gene therapy #Cold chain #Drug development #GSK #Pfizer #Regulatory #Supply chain

New podcast: A business case for drug discovery

This is the latest episode of the free DDW narrated podcast, “A business case for drug discovery”, which covers three articles written for Volume 23, Issue 3 – Summer 2022 of DDW. They are called “A deal in the making”, “Why project management… Read More

#News

#AI / data analytics / healthtech / informatics #Cell therapy #Cold chain

Cytiva and Brooks Life Sciences enhance automation in cold chain solutions

Cytiva and Brooks Life Sciences, a division of Brooks Automation, are working together to expand Cytiva’s Chronicle software capabilities to integrate Brooks Life Sciences BioStore III automated storage platform. This has been purpose built to handle a range of high value materials between the temperatures of -20°C and -190°C in… Read More

#News

#Cold chain #Covid-19 #Immunology / Virology & Vaccines

Keeping the cold chain unbroken for COVID research and vaccine development

Robin Vacha, Senior Vice President, Products at Brooks Life Sciences and David Lewandowski, Global Business Development Manager, Cryo Division at Brooks Life Sciences examine the role of unbroken cold chain in research and development As COVID-19 vaccine research continues to grow at an unparalleled pace, so does the need for… Read More

#Covid-19 #Exclusive Content